Mercury General (NYSE:MCY – Get Free Report) was downgraded by stock analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a research note issued to investors on Thursday.
Mercury General Stock Performance
MCY traded up $0.47 on Thursday, reaching $78.85. The company had a trading volume of 171,981 shares, compared to its average volume of 236,912. Mercury General has a fifty-two week low of $36.37 and a fifty-two week high of $79.76. The stock has a market cap of $4.37 billion, a P/E ratio of 7.81 and a beta of 0.81. The company’s fifty day moving average is $68.41 and its 200 day moving average is $61.24. The company has a debt-to-equity ratio of 0.31, a quick ratio of 0.33 and a current ratio of 0.33.
Mercury General (NYSE:MCY – Get Free Report) last announced its quarterly earnings results on Tuesday, October 29th. The insurance provider reported $2.54 EPS for the quarter, beating analysts’ consensus estimates of $1.15 by $1.39. Mercury General had a net margin of 10.18% and a return on equity of 18.04%. The business had revenue of $1.53 billion for the quarter, compared to analyst estimates of $1.37 billion. During the same quarter in the prior year, the business earned $1.14 EPS. As a group, analysts predict that Mercury General will post 6.35 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
Mercury General Company Profile
Mercury General Corporation, together with its subsidiaries, engages in writing personal automobile insurance in the United States. The company also writes homeowners, commercial automobile, commercial property, mechanical protection, and umbrella insurance products. Its automobile insurance products include collision, property damage, bodily injury, comprehensive, personal injury protection, underinsured and uninsured motorist, and other hazards; and homeowners insurance products comprise dwelling, liability, personal property, and other coverages.
Featured Articles
- Five stocks we like better than Mercury General
- Investing in Construction Stocks
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- Comparing and Trading High PE Ratio Stocks
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- What Do S&P 500 Stocks Tell Investors About the Market?
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Receive News & Ratings for Mercury General Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mercury General and related companies with MarketBeat.com's FREE daily email newsletter.